Apellis Pharmaceuticals Inc
(APLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AZN | AMGN | GILD | BMY |
| Company | Apellis Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 23.12 | 194.02 | 377.04 | 151.47 | 60.94 |
| High | 23.18 | 195.90 | 377.36 | 151.87 | 61.45 |
| Low | 22.80 | 190.60 | 366.88 | 149.35 | 59.95 |
| Latest | 22.83 | 193.85 | 368.92 | 149.60 | 60.54 |
| Change | +0.07 | +5.84 | -6.90 | -2.08 | -0.23 |
| % Change | +0.31% | +3.11% | -1.84% | -1.37% | -0.38% |
| Volume | 348,689 | 1,496,087 | 874,078 | 2,672,706 | 4,434,908 |
| 20-Day Average Volume | 3,659,854 | 4,640,749 | 3,040,920 | 7,962,142 | 13,259,672 |
| Previous Close | 22.83 | 188.01 | 375.82 | 151.68 | 60.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.05 | 187.36 | 347.67 | 137.40 | 56.49 |
| 20-Day Raw Stochastic | 75.62% | 85.95% | 73.64% | 89.61% | 84.54% |
| 20-Day Relative Strength | 49.67 | 57.46 | 61.63 | 71.54 | 68.09 |
| Weighted Alpha | +6.01 | +37.11 | +33.07 | +52.24 | +24.35 |
| Today's Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 64% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.72% since 02/03/26 | +4.88% since 02/03/26 | +8.66% since 02/03/26 | +4.49% since 02/03/26 | +8.47% since 02/03/26 |
| Low | 22.29 on 02/05/26 | 186.32 on 02/04/26 | 342.38 on 02/04/26 | 143.50 on 02/04/26 | 56.43 on 02/04/26 |
| High | 24.10 on 02/05/26 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -16.04% since 01/09/26 | +2.12% since 01/09/26 | +12.82% since 01/09/26 | +23.63% since 01/09/26 | +8.73% since 01/09/26 |
| Low | 19.26 on 01/20/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 26.55 on 01/12/26 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +20.63% since 11/10/25 | +10.49% since 11/10/25 | +13.67% since 11/10/25 | +26.71% since 11/10/25 | +28.51% since 11/10/25 |
| Low | 18.93 on 11/11/25 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 27.46 on 01/09/26 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -5.95% since 08/08/25 | +31.41% since 08/08/25 | +27.64% since 08/08/25 | +25.37% since 08/08/25 | +32.18% since 08/08/25 |
| Low | 18.75 on 11/07/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 30.48 on 10/28/25 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,888,566 | 291,586,208 | 202,371,936 | 188,186,336 | 123,712,712 |
| Shares Outstanding, K | 126,525 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 781,370,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -197,880,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 458,580,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 215,720,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.26 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.67 on 10/30/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/27/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 75.77 | 21.12 | 17.59 | 18.62 | 10.08 |